Monthly Archives: February 2017

BriaCell CEO Equity Investment Advances Company’s Lead Cancer Product and Pipeline Expansion
February 27, 2017

Berkeley, CA and Vancouver, BC – February 27, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Moves Forward to Initiate Phase I/IIa Clinical Study for BriaVax™ in Advanced Breast Cancer
February 6, 2017

Berkeley, CA and Vancouver, BC – February 6, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content